Total Payments
$20,856
2024 Payments
$1,641
Companies
78
Transactions
814
Medicare Patients
4,857
Medicare Billing
$545,509
Payment Breakdown by Category
Food & Beverage$17,735 (85.0%)
Education$2,357 (11.3%)
Travel$646.01 (3.1%)
Other$118.14 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,735 | 804 | 85.0% |
| Education | $2,357 | 3 | 11.3% |
| Travel and Lodging | $646.01 | 6 | 3.1% |
| Entertainment | $118.14 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,015 | 52 | $0 (2024) |
| Abbott Laboratories | $2,369 | 68 | $0 (2024) |
| SpineSmith Holdings, LLC | $2,350 | 1 | $0 (2017) |
| ABBVIE INC. | $1,274 | 68 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,092 | 66 | $0 (2024) |
| Amgen Inc. | $803.56 | 31 | $0 (2022) |
| Allergan, Inc. | $677.27 | 41 | $0 (2022) |
| SCILEX PHARMACEUTICALS INC. | $463.71 | 29 | $0 (2024) |
| Nevro Corp. | $444.94 | 15 | $0 (2023) |
| PFIZER INC. | $442.35 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,641 | 70 | Boston Scientific Corporation ($536.47) |
| 2023 | $2,179 | 93 | ABBVIE INC. ($600.92) |
| 2022 | $2,476 | 80 | BOSTON SCIENTIFIC CORPORATION ($394.81) |
| 2021 | $2,952 | 114 | BOSTON SCIENTIFIC CORPORATION ($664.48) |
| 2020 | $887.51 | 48 | Allergan, Inc. ($124.71) |
| 2019 | $2,321 | 153 | Zyla Life Sciences ($334.60) |
| 2018 | $3,087 | 161 | Abbott Laboratories ($607.67) |
| 2017 | $5,311 | 95 | SpineSmith Holdings, LLC ($2,350) |
All Payment Transactions
814 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Opioid Analgesic | ||||||
| 10/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $147.20 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: PAIN | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Gastroenterology | ||||||
| 08/22/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $37.58 | General |
| Category: Pain management | ||||||
| 08/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: Opioid Analgesic | ||||||
| 08/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 08/12/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Zimmer Biomet Holdings, Inc. | GPS III PLATELET CONCENTRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Sports Medicine | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,306 | 2,081 | $1.7M | $157,136 |
| 2022 | 21 | 1,413 | 2,157 | $1.8M | $154,464 |
| 2021 | 20 | 1,215 | 1,763 | $1.5M | $133,460 |
| 2020 | 21 | 923 | 1,574 | $1.2M | $100,449 |
Total Patients
4,857
Total Services
7,575
Medicare Billing
$545,509
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 374 | 651 | $493,328 | $62,852 | 12.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 308 | 492 | $88,560 | $29,376 | 33.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 83 | 106 | $191,737 | $11,099 | 5.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 39 | 43 | $147,868 | $9,394 | 6.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $85,765 | $9,310 | 10.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 28 | 48 | $68,336 | $4,596 | 6.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 19 | 21 | $73,009 | $4,246 | 5.8% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Facility | 2023 | 20 | 25 | $48,695 | $3,096 | 6.4% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 20 | 26 | $40,790 | $2,982 | 7.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 32 | 36 | $74,080 | $2,781 | 3.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 30 | 37 | $75,191 | $2,734 | 3.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 32 | 37 | $52,625 | $2,530 | 4.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 33 | $16,955 | $2,362 | 13.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 20 | 25 | $33,030 | $1,969 | 6.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 18 | 33 | $14,263 | $1,852 | 13.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 98 | 167 | $71,297 | $1,580 | 2.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 18 | 21 | $32,870 | $1,472 | 4.5% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 17 | 22 | $16,974 | $1,445 | 8.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 25 | 33 | $25,195 | $1,337 | 5.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 151 | $12,942 | $126.03 | 1.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 558 | $422,852 | $52,625 | 12.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 216 | 349 | $179,309 | $20,020 | 11.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 207 | 268 | $45,529 | $16,417 | 36.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 93 | 114 | $206,208 | $12,702 | 6.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 35 | 37 | $127,236 | $8,231 | 6.5% |
About Dr. Christopher Huser, MD
Dr. Christopher Huser, MD is a Anesthesiology healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932206604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Huser, MD has received a total of $20,856 in payments from pharmaceutical and medical device companies, with $1,641 received in 2024. These payments were reported across 814 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($17,735).
As a Medicare-enrolled provider, Huser has provided services to 4,857 Medicare beneficiaries, totaling 7,575 services with total Medicare billing of $545,509. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Englewood, CO
- Active Since 09/17/2006
- Last Updated 08/16/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1932206604
Products in Payments
- GENERAL PAIN MANAGEMENT (Device) $1,146
- DRG leads (Device) $801.81
- BOTOX (Biological) $730.99
- QULIPTA (Drug) $634.42
- XTAMPZA (Drug) $602.25
- Aimovig (Biological) $571.52
- Proclaim Family of SCS IPGs (Device) $561.89
- DRG IPGs (Device) $477.38
- UBRELVY (Drug) $465.79
- SPRIX (Drug) $433.89
- EMGALITY (Drug) $398.81
- General - Pain Management (Device) $394.81
- ZTLido (Drug) $375.38
- mild Device Kit (Device) $356.52
- ReActiv8 (Device) $348.57
- RELISTOR (Drug) $344.98
- Senza Spinal Cord Stimulation System (Device) $334.94
- NURTEC ODT (Drug) $300.54
- VYEPTI (Biological) $280.55
- Intracept (Device) $279.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Englewood
Aryeh Shander, Md, MD
Anesthesiology — Payments: $1.2M
Anesthesiology $1.2M
Giancarlo Checa, Md, MD
Anesthesiology — Payments: $102,543
Anesthesiology $102,543
Justin Merkow, M.d, M.D
Anesthesiology — Payments: $23,935
Anesthesiology $23,935
Adam Weingart, Md, MD
Anesthesiology — Payments: $16,558
Anesthesiology $16,558
Iasson Yi, Md, MD
Anesthesiology — Payments: $12,848
Anesthesiology $12,848
Dr. Alyssa Hamman, Md, MD
Anesthesiology — Payments: $6,048
Anesthesiology $6,048